PINI, Luigi Alberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 20.035
EU - Europa 10.454
AS - Asia 8.296
SA - Sud America 1.128
AF - Africa 161
Continente sconosciuto - Info sul continente non disponibili 128
OC - Oceania 15
Totale 40.217
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 19.685
GB - Regno Unito 3.423
IT - Italia 3.400
CN - Cina 2.552
SG - Singapore 2.336
HK - Hong Kong 942
VN - Vietnam 874
BR - Brasile 848
SE - Svezia 708
DE - Germania 549
UA - Ucraina 487
FI - Finlandia 429
FR - Francia 412
BD - Bangladesh 362
RU - Federazione Russa 287
KR - Corea 279
TR - Turchia 275
NL - Olanda 227
CA - Canada 196
BG - Bulgaria 171
IN - India 151
ID - Indonesia 126
AR - Argentina 89
IE - Irlanda 75
MX - Messico 74
IQ - Iraq 50
JP - Giappone 50
CO - Colombia 47
EC - Ecuador 47
ES - Italia 43
ZA - Sudafrica 41
BE - Belgio 38
AE - Emirati Arabi Uniti 37
PK - Pakistan 36
CL - Cile 31
CH - Svizzera 30
PL - Polonia 29
AT - Austria 28
MA - Marocco 26
VE - Venezuela 25
IR - Iran 24
PH - Filippine 21
MY - Malesia 20
BY - Bielorussia 18
TN - Tunisia 18
NP - Nepal 17
CR - Costa Rica 16
UZ - Uzbekistan 16
DZ - Algeria 15
SA - Arabia Saudita 15
EU - Europa 13
PY - Paraguay 13
IL - Israele 12
LT - Lituania 12
PE - Perù 12
RO - Romania 12
SN - Senegal 12
TH - Thailandia 12
EG - Egitto 11
JM - Giamaica 10
KE - Kenya 10
NO - Norvegia 10
UY - Uruguay 10
AU - Australia 9
ET - Etiopia 9
JO - Giordania 9
LB - Libano 9
NI - Nicaragua 9
GE - Georgia 8
KZ - Kazakistan 8
PT - Portogallo 8
TT - Trinidad e Tobago 8
AL - Albania 7
CZ - Repubblica Ceca 7
HN - Honduras 7
TW - Taiwan 7
AO - Angola 6
BH - Bahrain 6
BO - Bolivia 6
DO - Repubblica Dominicana 6
GR - Grecia 6
PA - Panama 6
RS - Serbia 6
SK - Slovacchia (Repubblica Slovacca) 6
YE - Yemen 6
AZ - Azerbaigian 5
GT - Guatemala 5
QA - Qatar 5
XK - ???statistics.table.value.countryCode.XK??? 5
BB - Barbados 4
DK - Danimarca 4
HU - Ungheria 4
PR - Porto Rico 4
PS - Palestinian Territory 4
SI - Slovenia 4
CY - Cipro 3
EE - Estonia 3
KG - Kirghizistan 3
KW - Kuwait 3
LK - Sri Lanka 3
Totale 40.062
Salva come PNG Salva come JPEG
Città #
Southend 2.672
Ashburn 1.883
Santa Clara 1.774
Fairfield 1.719
Singapore 1.427
Woodbridge 1.392
Jacksonville 1.012
Houston 975
Hefei 922
Hong Kong 919
Chandler 799
Dearborn 640
Wilmington 640
San Jose 621
Seattle 604
Cambridge 573
Ann Arbor 561
Council Bluffs 504
Beijing 469
London 399
Nyköping 361
Milan 343
Los Angeles 330
Chicago 285
Ho Chi Minh City 274
Helsinki 272
Seoul 261
The Dalles 257
Hanoi 218
New York 202
Modena 201
Princeton 198
Rome 177
San Diego 176
Sofia 167
Eugene 162
Buffalo 151
Dallas 150
Lauterbourg 148
Izmir 142
Moscow 105
Columbus 102
Salt Lake City 87
Turin 80
Jakarta 78
Bologna 75
Naples 75
Shanghai 72
Des Moines 71
Redwood City 69
Dublin 68
Orem 68
São Paulo 63
Toronto 51
Phoenix 50
Genoa 45
Palermo 44
Tokyo 44
Atlanta 43
Florence 41
Haiphong 40
Tampa 39
Brooklyn 38
Da Nang 37
Elk Grove Village 37
Nanjing 37
Rio de Janeiro 37
Verona 37
Brescia 35
Brussels 35
Frankfurt am Main 35
Dong Ket 33
Boardman 32
Ottawa 32
San Francisco 32
Miami 31
Norwalk 31
Catania 30
Bianco 29
Chennai 29
Denver 29
Bremen 28
Lancaster 28
Paris 28
Falkenstein 27
Guangzhou 27
Montreal 27
Munich 27
Philadelphia 27
Falls Church 26
Mexico City 26
Miano 25
Perugia 25
Parma 23
Boston 22
Sterling 22
Tulare 22
Baghdad 20
Fremont 20
Jinan 20
Totale 27.496
Salva come PNG Salva come JPEG
Nome #
La flunarizina nella profilassi delel crisi emicraniche delle cefalee cclassiche e comuni 2.341
A double-blind, randomized, multicenter, Italian study of frovatriptan versus almotriptan for the acute treatment of migraine. 804
Effect of acetylsalicylic acid on formalin test and on serotonin system in the rat brain. 451
OPPIACEI: FARMACOCINETICA, DIPENDENZA, DETOSSIFICAZIONE, TRATTAMENTI AGONISTI ED ANTAGONISTI 443
The antinociceptive effect of acetylsalicylic acid is differently affected by a CB1 agonist or antagonist and involves the serotonergic system in rats 404
Effect of acute and repeated administration of paracetamol on opioidergic and serotonergic systems in rats. 382
Basal cutaneous pain threshold in headache patients 380
Differential involvement of central 5-HT1B and 5-HT3 receptor subtypes in the antinociceptive effect of paracetamol 374
Serum protein changes in a rat model of chronic pain show a correlation between animal and humans 374
A genome-wide analysis in cluster headache points to neprilysin and PACAP receptor gene variants 372
Differential involvement of opioidergic and serotoninergic systems in the antinociceptive activity of N-arachidonoyl-phenolamine (AM404) in the rat: comparison with paracetamol 366
Endocannabinoids in chronic migraine: CSF findings suggest a system failure 363
Serotonergic and opiatergic modifications induced by paracetamol as a model for daily chronic headache with analgesic overuse 357
Nimodipine in otolaryngology: from past evidence to clinical perspectives 348
Proteomic analysis of urine in medication-overuse headache patients: possible relation with renal damages 345
BRAIN-SEROTONIN BINDING-CAPACITY, ANALGESIA AND DRUG SERUM LEVELS AFTER ACUTE TREATMENT WITH PHENAZONE IN RATS 320
Validation of potential candidate biomarkers of drug-induced nephrotoxicity and allodynia in medication-overuse headache 318
A case-control study of visually evoked postural responses in childhood with primary headaches 318
Central antinociceptive activity of acetylsalicylic acid is modulated by brain serotonin receptor subtypes 315
Discovery by a proteomic approach of possible early biomarkers of drug-induced nephrotoxicity in medication-overuse headache 312
Exploration of candidate serum biomarkers potentially related to the chronic pain condition in Medication-overuse headache 312
Nociceptin/orphanin FQ prevents the antinociceptive action of paracetamol on the rat hot plate test 309
Abnormalities in the cerebrospinal fluid levels of endocannabinoids in multiple sclerosis 309
A preliminary study on the relationship between central auditory processing and childhood primary headaches in the intercritical phase 306
Proteomic research of proteins involved in pain expression in an animal model of chronic pain 306
Diamo parole al dolore. La percezione del disagio e della difficoltà nella vita quotidiana delle bambine e dei bambini 296
Disposition of naproxen after oral administration during and between migraine attacks. 296
Valutazione del contenuto plasmatico e possibile uso terapeutico del glutatione in pazienti con cefalea cronica quotidiana ed uso giornaliero di associazioni analgesiche 296
Italian guidelines for primary headaches: 2012 revised version. 295
Effect of rofecoxib on nociception and the serotonin system in the rat brain 294
NF-kappa B activity and iNOS expression in monocytes from internal jugular blood of migraine without aura patients during attacks 293
Pharmacokinetics and tolerability of oral cannabis preparations in patients with medication overuse headache (MOH)—a pilot study 285
O015. Evaluation of the genetic polymorphism of the α3 (CHRNA3) and α5 (CHRNA5) nicotinic receptor subunits, in patients with cluster headache 283
A case of a GH-producing pituitary adenoma associated with a unilateral headache with autonomic signs 281
HIGH EFFICACY AND LOW-FREQUENCY OF HEADACHE RECURRENCE AFTER ORAL SUMATRIPTAN 280
Anti-epileptic drugs in the preventive treatment of migraine headache : a brief review. 280
Long-term follow-up of patients treated for chronic headache with analgesic overuse 277
Acetylsalicyclic acid potentiates the antinociceptive effect of morphine in the rat:involvement of the central serotonergic system. 277
Headaches associated with chronic use of analgesics: A therapeutic approach 276
Genetic variation in CHRNA7 and CHRFAM7A is associated with nicotine dependence and response to varenicline treatment 276
A genetic association study of dopamine metabolism-related genes and chronic headache with drug abuse 273
Nabilone for the treatment of medication overuse headache: results of a preliminary double-blind, active-controlled, randomized trial. 269
Effects of chronic treatment with phenazone on the hot plate test and [3H]-Serotonin binding sites in pons and cortex membranes of the rat 262
Serum changes of apolipoproteins in Medication Overuse Headache (MOH) 262
THE ROLE OF SEROTONIN BRAIN RECEPTORS IN THE ANALGESIC EFFECT OF PHENAZONE 261
The potentiation of analgesic activity of paracetamol plus morphine involves the serotonergic system in rat brain 259
INFLUENCE OF PROLONGED THERAPY WITH FLUNARIZINE ON GLUCOSE, INSULIN AND C-PEPTIDE METABOLISM 259
INTERNATIONAL-HEADACHE-SOCIETY CLASSIFICATION - INTEROBSERVER RELIABILITY IN THE DIAGNOSIS OF PRIMARY HEADACHES 258
PHYSIOLOGICAL-PARAMETERS AND PLASMA-LEVELS AFTER SHORT AND LONG-TERM PROPOFOL INFUSION 257
Analgesic abuse in chronic headache sufferers 257
Clinical-biochemical correlates of migraine attacks in rizatriptan responders and non-responders 255
An unusual case report on the possible role of Warfarin in migraine prophylaxis 253
PHARMACOKINETICS OF TIAPROFENIC ACID AFTER ORAL-ADMINISTRATION IN FASTING PATIENTS DURING AND BETWEEN MIGRAINE ATTACKS 252
Phenytoin-Treatment Of Rdeb Vegetans 252
PHARMACOKINETIC OF REDUCED GLUTATHIONE IN MAN - EFFECT ON PLASMA CYSTEINE AND THIOL COMPOUNDS 252
Lack of activity of Ketorolac in hot-plate test and serotonin binding capacity of brain membranes in rats 251
The effect of paracetamol and morphine combination on dynorphin A levels in the rat brain. 246
Lack of association between five serotonin metabolism-relatedgenes and medication overuse headache. 245
Serotonin and opiate involvement in the antinociceptive effect of acetylsalicylic acid 243
Pharmacological outline of chronic headache patients: overlap between depressive and nociceptive symptomatology 243
The antinociceptive action of paracetamol is associated with changes in the serotonergic system in the rat brain 242
Risk-benefit and cost-benefit ratio in headache treatment 242
Tolerability and efficacy of a combination of paracetamol and caffeine in the treatment of tension-type headache: a randomised, double-blind, double-dummy, cross-over study versus placebo and naproxen sodium 240
Urine proteomic analysis in patients with cronic headache and overuse of analgesic drugs: possible relation with renal damage 240
Evaluation of a possible relationship between medication-overuse headache and potential renal dysfunctions by a proteomic study on urine samples 239
CHRNA5 polymorphism and nicotine dependence in patients with cluster headache 238
The effect of chronic treatment with phenazone on [3H]-serotonin binding sites in pons and cortex membranes of the rat 237
Migraine preventive drug-induced weight gain may be mediated by effects on hypothalamic peptides: the results of a pilot study. 231
Switching from HPLC/UV to MEIA for whole blood sirolimus quantitation: Comparison of methods 231
Plasma glutathione level in chronic headache drug abuser patients 230
Analysis on the use of migraine preventative drugs in current clinical practice 230
The effect of Paracetamol on nociception and dynorphin A levels in the rat brain 230
Different characteristics of triptans 228
An emerging problem in clinical practice: how to treat chronic headache patients. 228
Chronic daily headache: how to manage it? 226
Triptans: the experience of a clinical pharmacologist in clinical practice. 225
Plasma glutathione level in paracetamol daily abuser patients. Changes in plasma cysteine and thiol groups after reduced glutathione administration 225
Involvement of brain serotonergic system in the antinociceptive action of acetylsalicylic acid in the rat 224
DOES CHRONIC USE OF SUMATRIPTAN INDUCE DEPENDENCE 224
Plasma reduced glutathione level and changes in thiol groups after glutathione administration in drug abuser patients - 220
Relevance of analgesic abuse in the maintenance of chronic headaches 220
Homocysteine levels and cardiovascular disease in migraine with aura 220
Endocannabinoids in platelets of chronic migraine patients and medication-overuse headache patients: relation with serotonin levels 220
High prevalence of patent foramen ovale in migraine with aura 219
Pharmacokinetics of tia profenic acid in headache attacks - a preliminary report 218
Tacrolimus pharmacokinetics in kidney transplant recipients. 217
Ambiti e limiti delle prescrizioni farmaceutiche nell'esercizio dell'odontoiatria e protesi dentaria 217
Naloxone-reverisble antinociception by paracetamol in the rat. 215
Frovatriptan versus almotriptan for acute treatment of menstrual migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study 215
Active reporting scheme: an example to evaluate specific adverse drug reactions. 215
Topo-kinesthetic memory in chronic headaches. A new test for chronic patients: preliminary report 214
Influence of chronic therapy with flunarizine on glucose, insulin and C-peptide metabolism 212
PHARMACOKINETICS OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS 211
Impact of continuing or quitting smoking on episodic cluster headache: a pilot survey 211
A CB1 agonist in the treatment of medication-overuse headache: a possible therapeutic strategy 211
EFFECTS OF ACETYLSALICYCLIC ACID ON SEROTONIN BRAIN RECEPTOR SUBTYPES 211
Urinary neopterin in malignant lymphoma 210
Preclinical pharmacological profile of the selective 5-HT1F receptor agonist lasmiditan. A comment. 209
Circadian variations of proopiocortin-related peptides in children with migraine. 209
Ethanol causes neurogenic vasodilation by TRPV1 activation and CGRP release in the trigeminovascular system of the guinea pig 209
Totale 29.536
Salva come PNG Salva come JPEG
Categoria #
all - tutte 146.426
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 146.426
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.393 0 0 319 326 66 75 194 139 279 198 443 354
2022/20232.399 308 231 141 208 268 363 49 213 300 51 120 147
2023/20242.231 116 143 158 171 370 166 200 268 93 83 223 240
2024/20256.336 282 117 155 473 1.230 883 341 311 840 467 595 642
2025/202611.263 716 540 1.207 1.289 1.331 822 1.203 664 1.084 947 826 634
2026/20271.992 540 1.028 424 0 0 0 0 0 0 0 0 0
Totale 40.217